Leerink Swann Reiterates an 'Outperform' on Regeneron Pharma (REGN); Survey Says: Solid Eylea Outlook in U.S.
Go back to Leerink Swann Reiterates an 'Outperform' on Regeneron Pharma (REGN); Survey Says: Solid Eylea Outlook in U.S.| Regeneron (NASDAQ: REGN) | Delayed: 834.04 +7.40 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $826.64 | 52 Week High | $592.36 | |||
| Open | $835.74 | 52 Week Low | $325.35 | |||
| Day High | $847.00 | P/E | 218.91 | |||
| Day Low | $826.64 | EPS | $3.81 | |||
| Volume | 786,840 | |||||

